Finally, we will discuss CD44 and STAT3 involvement in cancer-driven metabolism switches and summarize currently available data on CD44 therapeutic targeting alone or in combination with STAT3, highlighting promising therapeutic opportunities for the future. Here, CD44 is linked to cancer.